# Patent

## Title
Methods of optimizing substrate pools and biosynthesis of

## Abstract

This application is the 35 USC .sctn.371 National phase of International application PCT/FR95/00957 filed Jul. 18, 1995, which designated the United States of America.

## Background
The invention relates to a process for producing fatty acids or derivatives of fatty acids (esters or other derivatives) from oleaginous plants. The process of the invention applies in particular to oleoproteaginous plants such as rapeseed, sunflower, soya, kale, etc. The invention may in particular be used to produce biofuels (diesters), lubricants, phytosanitary adjuvants, detergents, etc., by converting the resultant fatty acids.

Since 1970 numerous attempts have been made to replace products derived from petroleum (in particular fuels) by products obtained from vegetable matter so as to reduce the dependency on oil-producing countries and increase the markets and sales of agricultural products. The industrial route utilizing oleaginous plants as starting materials starts from the production of free fatty acids constituting the raw materials for the conversion industries and ends up with fuels, lubricants, etc. The lipids accumulated by the oleaginous plants may be converted into fatty acids by hydrolysis: two processes are currently used industrially to effect this conversion.

The first process consists in hydrolyzing the lipids after extraction by contacting the extracted lipids under conditions of heat and pressure with sulphuric acid/methanol or methanolic potassium hydroxide. Another process consists in carrying out the hydrolysis under similar conditions directly on the crushed seed material without prior extraction. Further details of these processes, which are the only ones used industrially to hydrolyze vegetable oils, may be found in the following reference: K. J. Harrington and C. d'Arcy-Evans, Ind. Eng. Chem. Prod. Res. Dev. 1985, 24, 314-318. The well-known high operating costs, large industrial infrastructure, polluting nature of the effluents, production of glycerol as a by-product without an existing market. These processes are used on account of the lack of simple alternatives.

In addition, experiments have been carried out in the laboratory to effect the hydrolysis of lipids enzymatically by mixing a lipase with the lipids extracted from seeds (G. P. McNeill et al., JAOCS, Vol. 68 No. 1st January 1991, p. 1-5; S. M. Kim and J. S. Rhee, JAOCS Vo. 68 No. 7th July 1991, p. 499-503; C. Gancet, In Heterogeneous Catalysis And Fine Chemicals II 1991, Guisnet Editors, p. 93-104). However, these experiments have remained at the laboratory stage since the technique is incompatible with an industrial exploitation on account of the amounts of enzyme required and the cost of the latter.

It should be emphasized that processes are already known enabling enzymes to be produced from plants (patent WO-A-92/01042 and EP-A-0.449.376). These processes lead to the linexpensive production of enzymes which are then used, after or without having been isolated, in various industrial or food industry conversion processes.

Nevertheless, this teaching is completely unconnected with the problem in question, which concerns the production of fatty acids directly from oleaginous plants.

The present invention aims to provide a new solution to the problem of producing fatty acids from oleaginous plants. The invention seeks to provide a solution whose costs of implementation are considerably less than known processes (industrial chemical processes as well as laboratory enzymatic processes).

An object of the invention is thus to provide a process that can be carried out on an industrial scale under mild temperature and pressure conditions, which is simple to operate and is non-polluting, employs a small-scale infrastructure, and does not produce any harmful by-product.

Another object, associated with the previous one, is to enable the number of fatty acid production installations to be increased so that they can be sited close to the regions of cultivation of the oleaginous plants and thereby achieve savings in transportation of raw materials.

To this end, the process according to the invention for producing fatty acids or fatty acid derivatives from oleaginous plants is characterized in that: one gene coding for a lipase enzyme, the so-called lipase gene, and on the other hand, associated with this lipase gene, a promoter permitting an expression of the gene either in cellular, extracellular or tissue compartments other than those in which the plant lipids accumulate, or permitting exogenous induction, as to bring into mutual contact the lipids and lipase contained in the seeds or fruits, p1 the mixture is allowed to incubate to effect an enzymatic hydrolysis of the lipids of the ground material under the catalytic action of the lipase contained in the said crushed material, order to obtain the desired fatty acid derivatives.

The process of the invention is thus an enzymatic hydrolysis process that enjoys the advantages of this type of process (mild operating conditions, absence of pollution, small-scale and inexpensive installations, no harmful by-products). In this process the plant itself is induced to produce the enzyme necessary for the subsequent transformation of the lipids, this enzyme being prevented from coming into contact prematurely with the lipids so as to avoid any risk of self-degradation of the plant before harvesting. The hydrolysis then takes place without the addition of exogenous enzyme by bringing the lipids and enzymes produced by the plant into contact. Such a process has a particularly low overall operating cost. The crushing and incubating units are light and small-scale and are known in the agricultural industry, which means that these operations can be carried out at the sites where the plants are harvested.

The production of the transgenic plants is carried out by first of all effecting the genetic transformation of a natural oleaginous plant, causing the genetically transformed plant to reproduce sexually so as to produce transgenic seeds, and then using these seeds to obtain transgenic plant progeny.

The initial genetic transformation consists, according to a presently well-known process, of generating an expression cassette containing the lipase gene and the expression promoter of this gene and introducing this expression cassette into the genome of the plant.

One of the essential characteristics of the process of the invention is that the promoter associated with the lipase gene is adapted to prevent any premature contact of the enzyme and lipids; this promoter may be of various types: it may either (1) direct the expression of the gene in compartments other than those where the lipids accumulate, or (2) initiate the expression of the gene at a suitable moment by exogenous induction.

In the first case, two types of expression cassettes may be used: controlling the expression of this gene in a cellular or tissue compartment different from the lipid accumulation compartment, lipase gene provided with an address sequence for cellular or extracellular compartments other than those where the lipids accumulate.

In the second case (2) the promoter used in the expression cassette is of a type that can be controlled in an exogenous manner by physical, chemical or biochemical signals, in particular is a stress promoter controlling the expression by applying a physical shock to the seeds or fruits.

By way of example, to produce fatty acids from oleoproteaginous plants, the operating procedure 1A outlined above may be employed: expression cassette comprising a lipase gene and a promoter controlling the expression of a specific protein of the seed, and introducing this expression cassette into the genome of the plant so as to express the lipase in the compartments of the seed where the specified protein accumulates,

In the case of rapeseed, the promoter of the protein used is advantageously the napine promoter, which permits a large accumulation of lipase in the protein bodies of the seed, separated from the lipid globules.

The procedure 1B outlined above may be used regardless of the type of oleaginous plant, for example by choosing the constituent promoter 35S of CaMV (cauliflower mosaic virus) and the tobacco address sequence PR-S so as to direct the secretion of the produced lipases to the extracellular compartments. In this case too the lipids and lipases are brought into contact by simple crushing.

The procedure (2) outlined above may be used regardless of the type of oleaginous plant, for example by choosing the protease inhibition promoter isolated from potatoes, which controls gene expression in the case of injury or damage. The induction treatment that initiates the synthesis of the lipases may in this case be shelling or hulling of the seeds, carried out before crushing.

Regardless of the procedure that is chosen, preferably a gene is used coding for a non-specific lipase, i.e. characterized by a non-specific hydrolytic activity, in order to achieve a complete hydrolysis of the lipids accumulated by the plant and prevent interfering saponification reactions. However, for certain uses of fatty acids it is possible to cause the plant to produce lipases of specific hydrolytic activity so as to promote a certain type of hydrolysis (for example: monoacylglycerol lipase from penicyllium camembertii, effecting the hydrolysis of only one of the three fatty acid-glycerol bonds, so as to produce diacylglycerols).

In particular there may be used non-specific lipase genes, characterized by the following sequences or by sequences similar to the following sequences (the arrows define the coding part): .tangle-soliddn. 1   GATGACAACT TGGTTGGTGG CATGACTTTG GACTTACCCA GCGATGCTCC 51 TCCTATCAGC CTCTCTAGCT CTACCAACAG CGCCTCTGAT GGTGGTAAGG 101 TTGTTGCTGC TACTACTGCT CAGATCCAAG AGTTCACCAA GTATGCTGGT 151 ATCGCTGCCA CTGCCTACTG TCGTTCTGTT GTCCCTGGTA ACAAGTGGGA 201 TTGTGTCCAA TGTCAAAAGT GGGTTCCTGA TGGCAAGATC ATCACTACCT 251 TTACCTCCTT GCTTTCCGAT ACAAATGGTT ACGTCTTGAG AAGTGATAAA 301 CAAAAGACCA TTTATCTTGT TTTCCGTGGT ACCAACTCCT TCAGAAGTGC 351 CATCACTGAT ATCGTCTTCA ACTTTTCTGA CTACAAGCCT GTCAAGGGCG 401 CCAAAGTTCA TGCTGGTTTC CTTTCCTCTT ATGAGCAAGT TGTCAATGAC 451 TATTTCCCTG TCGTCCAAGA ACAATTGACC GCCCACCCTA CTTATAAGGT 501 CATCGTTACC GGTCACTCAC TCGGTGGTGC ACAAGCTTTG CTTGCCGGTA 551 TGGATCTCTA CCAACGTGAA CCAAGATTGT CTCCCAAGAA TTTGAGCATC 601 TTCACTGTCG GTGGTCCTCG TGTTGGTAAC CCCACCTTTG CTTACTATGT 651 TGAATCCACC GGTATCCCTT TCCAACGTAC CGTTCACAAG AGAGATATCG 701 TTCCTCACGT TCCTCCTCAA TCCTTCGGAT TCCTTCATCC CGGTGTTGAA 751 TCTTGGATGA AGTCTGGTAC TTCCAACGTT CAAATCTGTA CTTCTGAAAT 801 TGAAACCAAG GATTGCAGTA ACTCTATCGT TCCTTTCACC TCTATCCTTG {569 851 ACCACTTGAG TTACTTTGAT ATCAACGAAG GAAGCTGTTT GTAAAACACT 901 TGACGTGTTA CTCTAATTTT ATAATAAAAT TAAGTTTTTA TACAAT SEQUENCE II (SEQ ID NO: 2) 1  GTCGACCATT TCAGCCTGTT TTGCTCGCAA AACGACGCCG CGGGCGTGCG 51 CTACCGCACA CTCCGTCGCT GGGCGTTGTG CGGGGAAGAT TCAAACGAGC 101 GTTTCGCGCC GTAACAACCC GCTCTCTTCC GCTCTGCCAC GCAGGTTATG 151 ACCGGCCGCC AGGAAGCCGC GGATTTCCTG GCCTGGAGGA AAAAAGCCGA 201 AGCTGGCACG GTTCCTGGCG CAAGGGACAG CGAAGCGGTT CTCCCGGAAG 251 GATTCGGGCG ATGGCTGGCA GGACGCGCCC CTCGGCCCCA TCAACCTGAG .tangle-soliddn. 301 ATGAGAACAA CATGAAGAAG AAGTCTCTGC TCCCCCTCGG CCTGGCCATC 351 GGTCTCGCCT CTCTCGCTGC CAGCCCTCTG ATCCAGGCCA GCACCTACAC 401 CCAGACCAAA TACCCCATCG TGCTGGCCCA CGGCATGCTC GGCTTCGACA 451 ACATCCTCGG GGTCGACTAC TGGTTCGGCA TTCCCAGCGC CTTGCGCCGT 501 GACGGTGCCC AGGTCTACGT CACCGAAGTC AGCCAGTTGG ACACCTCGGA 551 AGTCCGCGGC GAGCAGTTGC TGCAACAGGT GGAGGAAATC GTCGCCCTCA 601 GCGGCCAGCC CAAGGTCAAC CTGATCGGCC ACAGCCACGG CGGGCCGACC 651 ATCCGCTACG TCGCCGCCGT ACGTCCCGAC CTGATCGCTT CCGCCACCAG 701 CGTCGGCGCC CCGCACAAGG GTTCGGACAC CGCCGACTTC CTGCGCCAGA 751 TCCCACCGGG TTCGGCCGGC GAGGCAGTCC TCTCCGGGCT GGTCAACAGC 801 CTCGGCGCGC TGATCAGCTT CCTTTCCAGC GGCAGCACCG GTACGCAGAA 851 TTCACTGGGC TCGCTGGAGT CGCTGAACAG CGAGGGTGCC GCGCGCTTCA 901 ACGCCAAGTA CCCGCAGGGC ATCCCCACCT CGGCCTGCGG CGAAGGCGCC 951 TACAAGGTCA ACGGCGTGAG CTATTACTCC TGGAGCGGTT CCTCGCCGCT 1001 GACCAACTTC CTCGATCCGA GCGACGCCTT CCTCGGCGCC TCGTCGCTGA 1051 CCTTCAAGAA CGGCACCGCC AACGACGGCC TGGTCGGCAC CTGCAGTTCG 1101 CACCTGGGCA TGGTGATCCG CGACAACTAC CGGATGAACC ACCTGGACGA 1151 GGTGAACCAG GTCTTCGGCC TCACCAGCCT GTTCGAGACC AGCCCGGTCA .tangle-soliddn. 1201 GCGTCTACCG CCAGCACGCC AACCGCCTGA AGAACGCCAG CCTGTAG SEQUENCE III (SEQ ID NO: 3) 1  GGGTGCATGC CAGCTCCCAC CGGACACCTG GCCCGTCGCT GAAACGTGTT .tangle-soliddn. 51 TTCGCTTTCT CTACAAATCC AACAACAGAG AGGCACTACC ATGGGTATCT 101 TTGACTATAA AAACCTTGGC ACCGAGGGTT CCAAAACGTT CTTCGCCGAT 151 GCCATGGCGA TCACGTTGTA TTCCTATCAC AACCTGGATA ACGGCTTTGC 201 CGTGGGCTAC CAGCACAACG GGTTGGGCTT GGGGCTACCG GCCACGCTGG 251 TCGGTGCGCT GCTCGGCAGC ACGGATTCCC AGGGCGTGAT CCCTGGCATC 301 CCGTGGAACC CGGATTCAGA AAAAGCCGCC CTTGAGGCGG TGCAGAAAGC 351 CGGTTGGACA CCGATCAGCG CCAGTGCCCT GGGCTACGCC GGCAAGGTCG 401 ATGCACGTGG CACCTTCTTT GGGGAAAAAG CCGGCTACAC CACGGCCCAG 451 GTCGAGGTAC TCGGCAAATA CGATGACGCC GGCAAGCTGC TCGAAATCGG 501 CATCGGTTTT CGTGGCACTT CGGGGCCACG GGAAACCTTG ATCAGCGACT 551 CGATCGGCGA CTTGATCAGC GATCTGCTCG CGGCCCTGGG GCCCAAGGAT 601 TACGCGAAAA ACTACGCCGG CGAAGCCTTC GGCGGCTTGC TCAAGAATGT 651 TGCCGACTAC GCCGGTGCCC ATGGCCTGAC CGGCAAGGAC GTGGTGGTCA 701 GCGGCCACAG CCTGGGCGGG CTGGCGGTCA ACAGCATGGC GGACTTGAGC 751 AACTACAAAT GGGCGGGGTT CTACAAGGAC GCCAACTATG TTGCCTATGC 801 CTCGCCGACC CAGAGTGCCG GCGACAAGGT GCTCAATATC GGTTACGAAA 851 ACGACCCGGT GTTCCGCGCG CTGGACGGCT CGTCGTTTAA CCTGTCGTCG 901 CTGGGCGTGC ACGACAAACC CCACGAGTCC ACCACCGATA ACATCGTCAG 951 CTTCAACGAC CACTACGCCT CGACGCTGTG GAATGTGCTG CCGTTTTCCA 1001 TCGTCAACCT GCCCACCTGG GTCTCGCATT TGCCGACGGC GTACGGCGAT 1051 GGCATGACGC GCATCCTCGA GTCCGGCTTC TACGACCAGA TGACCCGTGA 1101 CTCCACGGTG ATTGTTGCCA ACCTGTCCGA TCCGGCGCGG GCCAACACCT 1151 GGGTGCAGGA CCTCAACCGC AATGCCGAGC CCCACAAGGG CAACACGTTC 1201 ATCATCGGCA GCGACGGCAA CGACCTGATC CAGGGCGGCA ACGGTGCGGA 1251 CTTTATCGAG GGTGGCAAAG GCAACGACAC GATCCGCGAC AACAGCGGGC 1301 ACAACACCTT TTTGTTCAGC GGCCACTTTG GCAATGATCG CGTGATTGGC 1351 TACCAGCCCA CCGACAAACT GGTGTTCAAG GACGTGCAAG GAAGCACCGA 1401 CCTGCGTGAC CACGCGAAGG TGGTCGGCGC CGATACGGTG CTTACGTTTG 1451 GGGCCGACTC GGTGACGCTG GTCGGCGTGG GGCATGGCGG GCTGTGGACG .tangle-soliddn. 1501 GAGGGCGTGG TGATCGGCTG ATTACTCACG CAACCGATCA GTGCCAGTGC 1551 TGCCCCCGCC AGCCACCGCC CCAATTGGGC CGGTGGGGGT AGCCATAGCC SEQUENCE IV (SEQ ID NO: 4) 1  GGGCGATGGC TGGCAGGACG CGCCCCTCGG CCCCATCAAC CTGAGATGAG 51 AACAACATGA AGAAGAAGTC TCTGCTCCCC CTCGGCCTGG CCATCGGCCT .tangle-soliddn. 101 CGCCTCTCTC GCTGCCAGCC CTCTGATCCA GGCCAGCACC TACACCCAGA 151 CCAAATACCC CATCGTGCTG GCCCACGGCA TGCTCGGCTT CGACAATATC 201 CTCGGGGTCG ACTACTGGTT CGGCATTCCC AGCGCCTTGC GCCGTGACGG 251 TGCCCAGGTC TACGTCACCG AAGTCAGCCA GTTGGACACC TCGGAAGTCC 301 GCGGCGAGCA GTTGCTGCAA CAGGTGGAGG AAATCGTCGC CCTCAGCGGC 351 CAGCCCAAGG TCAACCTGAT CGGCCACAGC CACGGCGGGC CGACCATCCG 401 CTACGTCGCC GCCGTACGTC CCGACCTGAT GCCTTCCGCC ACCAGCGTCG 451 GCGCCCCGCA CAAGGGTTCG GACACCGCCG ACTTCCTGCG CCAGATCCCA 501 CCGGGTTCGG CCGGCGAGGC AGTCCTCTCC GGGCTGGTCA ACAGCCTCGG 551 CGCGCTGATC AGCTTCCTTT CCAGCGGCAG CGCCGGTACG CAGAATTCAC 601 TGGGCTCGCT GGAGTCGCTG AACAGCGAGG GGGCCGCGCG CTTCAACGCC 651 AAGTACCCGC AGGGCATCCC CACCTCGGCC TGCGGCGAAG GCGCCTACAA 701 GGTCAACGGC GTGAGCTATT ACTCCTGGAG CGGTTCCTCG CCGCTGACCA 751 ACTTCCTCGA TCCGAGCGAC GCCTTCCTCG GCGCCTCGTC GCTGACCTTC 801 AAGAACGGCA CCGCCAACGA CGGCCTGGTC GGCACCTGCA GTTCGCACCT 851 GGGCATGGTG ATCCGCGACA ACTACCGGAT GAACCACCTG GACGAGGTGA 901 ACCAGGTCTT CGGCCTCACC AGCCTGTTCG AGACCAGCCC GGTCAGCGTC .tangle-soliddn. 951 TACCGCCAGC ACGCCAACCG CCTGAAGAAC GCCAGCCTGT AGGACCCCGG 1001 CCGGGGCCTC GGCCCCGGCC CTTTCCCGGA AGCCCCCTCG CGTGAAGAAA 1051 ATCCTCCTGC TGATTCCACT GGCGTTCGCC GCCAGCCTGG CCTGGTTCGT SEQUENCE V (SEQ ID NO: 5) .tangle-soliddn. 1  CAGGCCCCCA CGGCCGTTCT TAATGGCAAC GAGGTCATCT CTGGTGTCCT 51 TGGGGCAAG GTTGATACCT TTAAGGGAAT TCCATTTGCT GACCCTCCTG 101 TTGGTGACTT GCGGTTCAAG CACCCCCAGC CTTTCACTGG ATCCTACCAG 151 GGTCTTAAGG CCAACGACTT CAGCTCTGCT TGTATGCAGC TTGATCCTGG 201 CAATGCCATT TCTTGGCTTG ACAAAGTCGT GGGCTTGGGA AAGATTCTTC 251 CTGATAACCT TAGAGGCCCT CTTTATGACA TGGCCCAGGG TAGTGTCTCC 301 ATGAATGAGG ACTGTCTCTA CCTTAACGTT TTCCGCCCTG CTGGCACCAA 351 GCCTGATGCT AAGCTCCCCG TCATGGTTTG GATTTACGGT GGTGCCTTTG 401 TGTTTGGTTC TTCTGCTTCT TACCCTGGTA ACGGCTACGT CAAGGAGAGT 451 GTGGAAATGG GCCAGCCTGT TGTGTTTGTT TCCATCAACT ACCGTACCGG 501 CCCCTATGGA TTCCTGGGTG GTGATGCCAT CACCGCTGAG GGTAACACCA 551 ACGCTGGTCT GCACGACCAG CGCAAGGGTC TCGAGTGGGT TAGCGACAAC 601 ATTGCCAACT TTGGTGGTGA TCCCGACAAG GTCATGATTT TCGGTGAGTC 651 CGCTGGTGCC ATGAGTGTTG CTCACCAGCT TGTTGCCTAC GGTGGTGACA 701 ACACCTACAA CGGAAAGAAG CTTTTCCACT CTGCCATTCT TCAGTCTGGC 751 GGTCCTCTTC CTTACTTTGA CTCTACTTCT GTTGGTCCCG AGAGTGCCTA 801 CAGCAGATTT GCTCAGTATG CCGGATGTGA TGCCAGCGCC AGTGACAATG 851 AAACTCTGGC TTGTCTCCGC AGCAAGTCCA GCGATGTCTT GCACAGTGCC 901 CAGAACTCGT ACGATCTCAA GGACCTGTTT GGCCTGCTCC CTCAATTCCT 951 TGGATTTGGT CCCAGACCCG ACGGCAACAT TATTCCCGAT GCCGCTTATG 1001 AGCTCTACCG CAGCGGTAGA TACGCCAAGG TTCCCTACAT TACTGGTAAC 1051 CAGGAGGATG AGGGTACTAT TCTTGCCCCC GTTGCTATTA ATGCTACCAC 1101 GACTCCCCAT GTTAAGAAGT GGTTGAAGTA CATTTGTAGC GAGGCTTCTG 1151 ACGCTTCGCT TGATCGTGTT TTGTCGCTCT ACCCCGGCTC TTGGTCGGAG 1201 GGTGCGCCAT TCCGCACTGG TATTCTTAAT GCTCTGACCC CTCAGTTCAA 1251 GCGCATTGCT GCCATTTTCA CTGATTTGCT GTTCCAGTCT CCTCGTCGTG 1301 TTATGCTTAA CGCTACCAAG GACGTCAACC GCTGGACTTA CCTTGCCACC 1351 CAGCTCCATA ACCTCGTTCC ATTTTTGGGT ACTTTCCATG GTAGTGATCT 1401 TCTTTTCCAA TACTACGTGG ACCTTGGCCC ATCTTCTGCT TACCGCCGCT 1451 ACTTTATCTC GTTTGCCAAC CACCACGACC CCAACGTTGG CACCAACCTG 1501 AAACAGTGGG ATATGTACAC TGATGCAGGC AAGGAGATGC TTCAGATTCA 1551 TATGGTTGGT AACTCTATGA GAACTGACGA CTTTAGAATC GAGGGAATCT .tangle-soliddn. 1601 CGAACTTTGA GTCTGACGTT ACTCTCTTCG GTTAA SEQUENCE VI (SEQ ID NO: 6) 1                                                 .tangle-soliddn. 1  ATGGAGCTCG CTCTTGCGCT CCTGCTCATT GCCTCGGTGG CTGCTGCCCC 51 CACCGCCACG CTCGCCAACG GCGACACCAT CACCGGTCTC AACGCCATCA 101 TCAACGAGGC GTTCCTCGGC ATTCCCTTTG CCGAGCCGCC GGTGGGCAAC 151 CTCCGCTTCA AGGACCCCGT GCCGTACTCC GGCTCGCTCG ATGGCCAGAA 201 GTTCACGCTG TACGGCCCGC TGTGCATGCA GCAGAACCCC GAGGGCACCT 251 ACGAGGAGAA CCTCCCCAAG GCAGCGCTCG ACTTGGTGAT GCAGTCCAAG 301 GTGTTTGAGG CGGTGCTGCC GCTGAGCGAG GACTGTCTCA CCATCAACGT 351 GGTGCGGCCG CCGGGCACCA AGGCGGGTGC CAACCTCCCG GTGATGCTCT 401 GGATCTTTGG CGGCGGGTTT GAGGTGGGTG GCACCAGCAC CTTCCCTCCC 451 GCCCAGATGA TCACCAAGAG CATTGCCATG GGCAAGCCCA TCATCCACGT 501 GAGCGTCAAC TACCGCGTGT CGTCGTGGGG GTTCTTGGCT GGCGACGAGA 551 TCAAGGCCGA GGGCAGTGCC AACGCCGGTT TGAAGGACCA GCGCTTGGGC 601 ATGCAGTGGG TGGCGGACAA CATTGCGGCG TTTGGCGGCG ACCCGACCAA 651 GGTGACCATC TTTGGCGAGC TGGCGGGCAG CATGTCGGTC ATGTGCCACA 701 TTCTCTGGAA CGACGGCGAC AACACGTACA AGGGCAAGCC GCTCTTCCGC 751 GCGGGCATCA TGCAGCTGGG GGCCATGGTG CCGCTGGACG CCGTGGACGG 801 CATCTACGGC AACGAGATCT TTGACCTCTT GGCGTCGAAC GCGGGCTGCG 851 GCAGCGCCAG CGACAAGCTT GCGTGCTTGC GCGGTGTGCT GAGCGACACG 901 TTGGAGGACG CCACCAACAA CACCCCTGGG TTCTTGGCGT ACTCCTCGTT 951 GCGGTTGCTG TACCTCCCCC GGCCCGACGG CGTGAACATC ACCGACGACA 1001 TGTACGCCTT GGTGCGCGAG GGCAAGTATG CCAACATCCC TGTGATCATC 1051 GGCGACCAGA ACGACGAGGG CACCTTCTTT GGCACCCTGC TGTTGAACGT 1101 GACCACGGAT GCCCAGGCCC GCGAGTACTT CAAGCAGCTG TTTGTCCACG 1151 CCAGCGACGC GGAGATCGAC ACGTTGATGA CGGCGTACCC CGGCGACATC 1201 ACCCAGGGCC TGCCGTTCGA CACGGGTATT CTCAACGCCC TCACCCCGCA 1251 GTTCAAGAGA ATCCTGGCGG TGCTCGGCGA CCTTGGCTTT ACGCTTGCTC 1301 GTCGCTACTT CCTCAACCAC TACACCGGCG GCACCAAGTA CTCATTCCTC 1351 CTGAAGCAGC TCCTGGGCTT GCCGGTGCTC GGAACGTTCC ACTCCAACGA 1401 CATTGTCTTC CAGGACTACT TGTTGGGCAG CGGCTCGCTC ATCTACAACA 1451 ACGCGTTCAT TGCGTTTGCC ACGGACTTGG ACCCCAACAC CGCGGGGTTG 1501 TTGGTGAAGT GGCCCGAGTA CACCAGCAGC CTGCAGCTGG GCAACAACTT 1551 GATGATGATC AACGCCTTGG GCTTGTACAC CGGCAAGGAC AACTTCCGCA .tangle-soliddn. 1601 CCGCCGGCTA CGACGCGTTG TTCTCCAACC CGCCGCTGTT CTTTGTGTAA

The identification of the six aforementioned sequences is as follows in the "EMBL" and "GENE BANK" databank:

SEQUENCE I (SEQ ID NO:1)

LOCUS:RCHLIPASE, 946 bp ss mRNA PLN 23/01/93

DEFINITION:Rhizopus niveus mRNA for lipase, partial sequence

ACCESSION:D 12 680

SEQUENCE II (SEQ ID NO:2)

LOCUS:PALIPAG 1247 bp DNA BCT 21/07/93

DEFINITION:P airuginosa lip A gene for lipase

ACCESSION:X 63 390 S 43 732

SEQUENCE III (SEQ ID NO:3)

LOCUS:PSELIPASEE, 1700 bp ds-DNA BCT 15/04/92

DEFINITION:Pseudomonas fluorescens lipase gene, coplete cds

ACCESSION:M.86 350

SEQUENCE IV (SEQ ID NO:4)

LOCUS:PSELIPL, 1282 bp ds-DNA BCT 17/04/92

DEFINNITION:Pseudomonas sp. Lipl gene for lipase

ACCESSION:D 10166 D 90398

SEQUENCE V (SEQ ID NO:5)

LOCUS:GCU 02387, 1635 bp DNA PLN 07/10/93

DEFINITION:Geotrichum candidum NRRLY-553 Lipase gene, partial eds

ACCESSION:UO 2367

SEQUENCE VI (SEQ ID NO:6)

LOCUS:CCLIP1, 1733 bp DNA PLN 27/04/93

DEFINITION:C. Cylindracea LIP1 gene for lipase

ACCESSION:X 64703

The sequence I (SEQ ID NO:1) corresponds to a cDNA of Rhizopus niveus, the sequence II (SEQ ID NO:2) may be isolated from the genome of Pseudomonas aeruginosa, sequence III (SEQ ID NO:3) from Pseudomonas fluorescens, sequence IV (SEQ ID NO:4) from Pseudomonas sp, sequence V (SEQ ID NO:5) from Geotricum candidum, and sequence VI (SEQ ID NO:6) from Candida cylindracea.

In addition, the introduction of the expression cassette: lipase gene/expression promoter of this gene, into the genome of the oleaginous plant may be effected by any known protocol.

For example, according to the most common protocol at the present time, this expression cassette may be introduced into the genome of somatic cells of the plant by a transfer by means of the bacterium Agrobacterium tumefaciens. This introduction into the somatic cells of the plant may also be effected by any other known technique, in particular by electroporation, biolistics or by microinjection.

It is also possible to introduce the expression cassette into the genome of microspores of the plant by electroporation or biolistics.

In the protocol provided later by way of example, the technique of electroporation is described for introducing the cassettte into the microspores of rapeseed.

Reference may be made to the following document "P. J. J. Hooykaas and R. A. Schilperoort, TIBS August 1985, p. 305-309" for more details on the transfer technique by means of the bacterium Agrobacterium tumefaciens. It will be recalled that this technique consists in introducing the relevant expression cassette into the Ti plasmid of the bacterium, in particular by thermal shock, followed by contact between the bacterium and the leaf discs of the plant, allowing the whole to incubate until the expression cassette is transferred into the genome of the cells of the foliar discs, and cultivating these foliar discs on a succession of media to regenerate the transgenic plants.

Reference may also be made to the following document "J. A. Russell et al., In Vitro Cell. Dev. Biol., 1992, 28P, p. 97-105" for more details of the biolistics technique. It will be recalled that this technique consists in attaching the plasmid containing the expression cassette to gold or tungsten microspheres, shooting these microspheres by means of a particle gun onto the cells of the plant to be transformed, and cultivating these cells until regeneration of the transgenic plants has occurred.

Reference may be made to the following document "Crossway A and A1, 1986, Mol. Gen. Genet 202, 179-185" for more details of the technique of microinjection. It will be recalled that this technique consists in injecting the plasmid containing the expression cassette into protoplasts or very young embryos by means of microsyringes, and cultivating the protoplasts until regeneration of the transgenic plants has occurred.

After the lipase and lipids have been brought into contact by crushing, the mixture is left to incubate so as to effect enzymatic hydrolysis. This incubation is carried out under normal conditions, in particular between 20.degree. C. and 60.degree. C., for the time required to achieve a total or almost total hydrolysis.

The fatty acids produced by the hydrolysis are extracted and then worked up by any known process, in particular by liquid/liquid extraction using a non-polar solvent such as chloroform or hexane.

According to another procedure, it is possible to carry out an in situ conversion of the fatty acids to obtain fatty acid derivatives, which are then extracted. For example the fatty acids produced by the hydrolysis may be methylated in situ by mixing them with methanol under acid catalysis and ultrasound so as to convert the acids into methyl esters, which are then extracted by a liquid/liquid extraction using a non-polar solvent.

The present application provides, as a novel product, any oleaginous plant or oleaginous plant seed of a variety that is not protectable by a plant breeding certificate, which includes in its genome an expression cassette containing at least one gene coding for a lipase enzyme, associated with a promoter permitting an expression of the gene in cellular, extracellular or tissue compartments different from the lipid compartments of the plant or seed.

The promoter associated with the lipase gene may be a specific cellular expression or tissue expression promoter. This promoter may also be a constituent promoter, in which case the lipase gene is provided with an address sequence for cellular or extracellular compartments different from the lipid accumulation compartments.

The present application also covers any oleaginous plant or oleaginous plant seed of a variety that is not protectable by a plant breeding certificate, which includes in its genome an expression cassette having at least one gene coding for a lipase enzyme, associated with a promoter permitting an expression of the said gene by exogenous induction, in particular by a stress.

The following description together with the accompanying diagram provides by way of example a protocol for implementing the process of the invention; FIG. 1 of the diagram illustrates the preparation of the genetic material to be transferred. GENE

a) Plant material

Rapeseed (Brassica napus, Var Tapidor) seeds are used, which are commercially available.

The seeds are sown in a greenhouse and cultivated under normal conditions. The state of health of the plants is strictly monitored.

The young buds (size less than 3.5 mm) are picked, sterilized in sodium hypochlorite for 30 minutes, and the microspores are extracted from the anthers by crushing in a Waring Blender in the medium of Huang et al (Huang et al. 1990, Plant. Cell. Rep. 8, 594-597). After filtering through a 5 .mu.m mesh size metal sieve, the microspores are recovered by centrifugation for 5 minutes at 100 xg (protocol described in Jardinaud et al., 1993, Plant. Sci. 93, 177-184).

b) Genetic structure

The genetic structure that is adopted utilizes the napine promoter, the cDNA of Rhizopus niveus lipase and the NOS terminator. The napine promoter governs the expression of this protein in a protein compartment of the seed different from that in which the lipids accumulate. The whole arrangement is introduced into the PRT1 plasmid containing the pat selection gene used to screen the transformants so as to form the pRTlL structure.

Details of the structure are shown in FIG. 1 of the drawing.

The napine promoter designated "Prom. Nap" was isolated by Professor Rask's team (Stalberg K. et al, 1993, Plant Molecular Biology, 23:671-683). The Rhizopus niveus lipase cDNA, designated "Lip", was isolated by the Central Research Institute (Kugimiya et al., 1992, Biosci. Biotech. Biochem. 56, 716-719). An initiation codon, designated "start codon", compatible with the 5' end of the cDNA (available on the market) is grafted onto this end. A terminator designated NOS extracted from the pRT1 plasmid mentioned hereinbelow is grafted onto the 3' end, designated "lip", of the resultant arrangement, and the Nap promoter is grafted onto the 5' end.

The expression cassette thus obtained is introduced into a plasmid designated "Blue-Script" (commercial name) so that it can be amplified.

The amplified expression cassette is then extracted from "Blue-Script" and introduced into a plasmid designated pRT1, which was prepared by grafting the promoter designated CaMV35S onto the 5' end of the "pat" gene coding for phosphinothricine acetyl transferase (selection gene), and the NOS terminator onto the 3' end.

A plasmid designated pRTlL is obtained containing the desired expression cassette.

c) Gene transfer and production of transgenic plants

The microspores isolated in a) (10.sup.6 microspores ml.sup.-1) are suspended in Brewbaker and Kwack's medium (J. L. Brewbaker and B. H. Kwack, 1963, Am. J. Bot. 50, p. 859-865) containing 13% sucrose and adjusted to pH 5.9. 50 .mu.g per ml of the pRTlL plasmid are added to the medium and electrical pulses of 400 V/cm are applied for 10 ms to the suspension by means of a "Jouan" electroporation apparatus (trademark) (TRX, GHT) delivering square wave pulses. After 20 minutes' rest the culture medium (Huang et al.) containing 100 mg/l of phosphinothricine is added to the microspores. The microspores are cultivated in the dark for 24 hrs at 35.degree. C. and then at 25.degree. C. After two weeks of cultivation an equal volume of new medium is added and the microspores are exposed to cycles of 16 hours of light per day followed by 8 hours of darkness.

After about 1 month the embryos are transferred to B.sub.5 medium (Gamborg et al., 1979, Exp. Cell. Res. 50, 151-158) containing 1 ml/g of G3A.sub.3 and 20 g/l of sucrose, to which 8 g/l of "Bacto Agar" (trademark) gelling agent is added.

The phosphinothricine-resistant regenerated plants are analyzed by Southern blotting so as to verify the presence in their genome of the sequence coding for lipase. The chromosome complement of the plants is doubled by colchicine (0.1 g/l plus a few drops of Teepol) and the resultant fertile diploid plant are self-fertilized.

The activity of the lipase is investigated in a limited number of seeds. The plants having seeds with the greatest lipase activity are retained and the seeds are used to propagate the plants until enough seeds are obtained to perform the hydrolysis experiments on the seed lipids with endogenous lipase.

The seeds are crushed and the crushed material is placed in an incubator kept at a constant temperature of 40.degree.. The crushed material is constantly agitated to increase the contact between the lipids and the lipase.

After 48 hours hydrolysis, the fatty acids are extracted with chloroform. The chloroform is evaporated and the fatty acids are recovered. #             SEQUENCE LISTING - (1) GENERAL INFORMATION: -    (iii) NUMBER OF SEQUENCES: 6 - (2) INFORMATION FOR SEQ ID NO:1: -      (i) SEQUENCE CHARACTERISTICS: #pairs    (A) LENGTH: 946 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear -     (ii) MOLECULE TYPE: cDNA -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:1: - GATGACAACT TGGTTGGTGG CATGACTTTG GACTTACCCA GCGATGCTCC TC - #CTATCAGC 60 - CTCTCTAGCT CTACCAACAG CGCCTCTGAT GGTGGTAAGG TTGTTGCTGC TA - #CTACTGCT 120 - CAGATCCAAG AGTTCACCAA GTATGCTGGT ATCGCTGCCA CTGCCTACTG TC - #GTTCTGTT 180 - GTCCCTGGTA ACAAGTGGGA TTGTGTCCAA TGTCAAAAGT GGGTTCCTGA TG - #GCAAGATC 240 - ATCACTACCT TTACCTCCTT GCTTTCCGAT ACAAATGGTT ACGTCTTGAG AA - #GTGATAAA 300 - CAAAAGACCA TTTATCTTGT TTTCCGTGGT ACCAACTCCT TCAGAAGTGC CA - #TCACTGAT 360 - ATCGTCTTCA ACTTTTCTGA CTACAAGCCT GTCAAGGGCG CCAAAGTTCA TG - #CTGGTTTC 420 - CTTTCCTCTT ATGAGCAAGT TGTCAATGAC TATTTCCCTG TCGTCCAAGA AC - #AATTGACC 480 - GCCCACCCTA CTTATAAGGT CATCGTTACC GGTCACTCAC TCGGTGGTGC AC - #AAGCTTTG 540 - CTTGCCGGTA TGGATCTCTA CCAACGTGAA CCAAGATTGT CTCCCAAGAA TT - #TGAGCATC 600 - TTCACTGTCG GTGGTCCTCG TGTTGGTAAC CCCACCTTTG CTTACTATGT TG - #AATCCACC 660 - GGTATCCCTT TCCAACGTAC CGTTCACAAG AGAGATATCG TTCCTCACGT TC - #CTCCTCAA 720 - TCCTTCGGAT TCCTTCATCC CGGTGTTGAA TCTTGGATGA AGTCTGGTAC TT - #CCAACGTT 780 - CAAATCTGTA CTTCTGAAAT TGAAACCAAG GATTGCAGTA ACTCTATCGT TC - #CTTTCACC 840 - TCTATCCTTG ACCACTTGAG TTACTTTGAT ATCAACGAAG GAAGCTGTTT GT - #AAAACACT 900 #                946TTT ATAATAAAAT TAAGTTTTTA TACAAT - (2) INFORMATION FOR SEQ ID NO:2: -      (i) SEQUENCE CHARACTERISTICS: #pairs    (A) LENGTH: 1257 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear -     (ii) MOLECULE TYPE: cDNA -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:2: - GTCGACCATT TCAGCCTGTT TTGCTCGCAA AACGACGCCG CGGGCGTGCG CT - #ACCGCACA 60 - CTCCGTCGCT GGGCGTTGTG CGGGGAAGAT TCAAACGAGC GTTTCGCGCC GT - #AACAACCC 120 - GCTCTCTTCC GCTCTGCCAC GCAGGTTATG ACCGGCCGCC AGGAAGCCGC GG - #ATTTCCTG 180 - GCCTGGAGGA AAAAAGCCGA AGCTGGCACG GTTCCTGGCG CAAGGGACAG CG - #AAGCGGTT 240 - CTCCCGGAAG GATTCGGGCG ATGGCTGGCA GGACGCGCCC CTCGGCCCCA TC - #AACCTGAG 300 - ATGAGAACAA CATGAAGAAG AAGTCTCTGC TCCCCCTCGG CCTGGCCATC GG - #TCTCGCCT 360 - CTCTCGCTGC CAGCCCTCTG ATCCAGGCCA GCACCTACAC CCAGACCAAA TA - #CCCCATCG 420 - TGCTGGCCCA CGGCATGCTC GGCTTCGACA ACATCCTCGG GGTCGACTAC TG - #GTTCGGCA 480 - TTCCCAGCGC CTTGCGCCGT GACGGTGCCC AGGTCTACGT CACCGAAGTC AG - #CCAGTTGG 540 - ACACCTCGGA AGTCCGCGGC GAGCAGTTGC TGCAACAGGT GGAGGAAATC GT - #CGCCCTCA 600 - GCGGCCAGCC CAAGGTCAAC CTGATCGGCC ACAGCCACGG CGGGCCGACC AT - #CCGCTACG 660 - TCGCCGCCGT ACGTCCCGAC CTGATCGCTT CCGCCACCAG CGTCGGCGCC CC - #GCACAAGG 720 - GTTCGGACAC CGCCGACTTC CTGCGCCAGA TCCCACCGGG TTCGGCCGGC GA - #GGCAGTCC 780 - TCTCCGGGCT GGTCAACAGC CTCGGCGCGC TGATCAGCTT CCTTTCCAGC GG - #CAGCACCG 840 - GTACGCAGAA TTCACTGGGC TCGCTGGAGT CGCTGAACAG CGAGGGTGCC GC - #GCGCTTCA 900 - ACGCCAAGTA CCCGCAGGGC ATCCCCACCT CGGCCTGCGG CGAAGGCGCC TA - #CAAGGTCA 960 - ACGGCGTGAG CTATTACTCC TGGAGCGGTT CCTCGCCGCT GACCAACTTC CT - #CGATCCGA 1020 - GCGACGCCTT CCTCGGCGCC CCTCGGCGCC TCGTCGCTGA CCTTCAAGAA CG - #GCACCGCC 1080 - AACGACGGCC TGGTCGGCAC CTGCAGTTCG CACCTGGGCA TGGTGATCCG CG - #ACAACTAC 1140 - CGGATGAACC ACCTGGACGA GGTGAACCAG GTCTTCGGCC TCACCAGCCT GT - #TCGAGACC 1200 - AGCCCGGTCA GCGTCTACCG CCAGCACGCC AACCGCCTGA AGAACGCCAG CC - #TGTAG 1257 - (2) INFORMATION FOR SEQ ID NO:3: -      (i) SEQUENCE CHARACTERISTICS: #pairs    (A) LENGTH: 1600 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear -     (ii) MOLECULE TYPE: cDNA -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:3: - GGGTGCATGC CAGCTCCCAC CGGACACCTG GCCCGTCGCT GAAACGTGTT TT - #CGCTTTCT 60 - CTACAAATCC AACAACAGAG AGGCACTACC ATGGGTATCT TTGACTATAA AA - #ACCTTGGC 120 - ACCGAGGGTT CCAAAACGTT GTTCGCCGAT GCCATGGCGA TCACGTTGTA TT - #CCTATCAC 180 - AACCTGGATA ACGGCTTTGC CGTGGGCTAC CAGCACAACG GGTTGGGCTT GG - #GGCTACCG 240 - GCCACGCTGG TCGGTGCGCT GCTCGGCAGC ACGGATTCCC AGGGCGTGAT CC - #CTGGCATC 300 - CCGTGGAACC CGGATTCAGA AAAAGCCGCC CTTGAGGCGG TGCAGAAAGC CG - #GTTGGACA 360 - CCGATCAGCG CCAGTGCCCT GGGCTACGCC GGCAAGGTCG ATGCACGTGG CA - #CCTTCTTT 420 - GGGGAAAAAG CCGGCTACAC CACGGCCCAG GTCGAGGTAC TCGGCAAATA CG - #ATGACGCC 480 - GGCAAGCTGC TCGAAATCGG CATCGGTTTT CGTGGCACTT CGGGGCCACG GG - #AAACCTTG 540 - ATCAGCGACT CGATCGGCGA CTTGATCAGC GATCTGCTCG CGGCCCTGGG GC - #CCAAGGAT 600 - TACGCGAAAA ACTACGCCGG CGAAGCCTTC GGCGGCTTGC TCAAGAATGT TG - #CCGACTAC 660 - GCCGGTGCCC ATGGCCTGAC CGGCAAGGAC GTGGTGGTCA GCGGCCACAG CC - #TGGGCGGG 720 - CTGGCGGTCA ACAGCATGGC GGACTTGAGC AACTACAAAT GGGCGGGGTT CT - #ACAAGGAC 780 - GCCAACTATG TTGCCTATGC CTCGCCGACC CAGAGTGCCG GCGACAAGGT GC - #TCAATATC 840 - GGTTACGAAA ACGACCCGGT GTTCCGCGCG CTGGACGGCT CGTCGTTTAA CC - #TGTCGTCG 900 - CTGGGCGTGC ACGACAAACC CCACGAGTCC ACCACCGATA ACATCGTCAG CT - #TCAACGAC 960 - CACTACGCCT CGACGCTGTG GAATGTGCTG CCGTTTTCCA TCGTCAACCT GC - #CCACCTGG 1020 - GTCTCGCATT TGCCGACGGC GTACGGCGAT GGCATGACGC GCATCCTCGA GT - #CCGGCTTC 1080 - TACGACCAGA TGACCCGTGA CTCCACGGTG ATTGTTGCCA ACCTGTCCGA TC - #CGGCGCGG 1140 - GCCAACACCT GGGTGCAGGA CCTCAACCGC AATGCCGAGC CCCACAAGGG CA - #ACACGTTC 1200 - ATCATCGGCA GCGACGGCAA CGACCTGATC CAGGGCGGCA ACGGTGCGGA CT - #TTATCGAG 1260 - GGTGGCAAAG GCAACGACAC GATCCGCGAC AACAGCGGGC ACAACACCTT TT - #TGTTCAGC 1320 - GGCCACTTTG GCAATGATCG CGTGATTGGC TACCAGCCCA CCGACAAACT GG - #TGTTCAAG 1380 - GACGTGCAAG GAAGCACCGA CCTGCGTGAC CACGCGAAGG TGGTCGGCGC CG - #ATACGGTG 1440 - CTTACGTTTG GGGCCGACTC GGTGACGCTG GTCGGCGTGG GGCATGGCGG GC - #TGTGGACG 1500 - GAGGGCGTGG TGATCGGCTG ATTACTCACG CAACCGATCA GTGCCAGTGC TG - #CCCCCGCC 1560 #  1600            GGGC CGGTGGGGGT AGCCATAGCC - (2) INFORMATION FOR SEQ ID NO:4: -      (i) SEQUENCE CHARACTERISTICS: #pairs    (A) LENGTH: 1100 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear -     (ii) MOLECULE TYPE: cDNA -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:4: - GGGCGATGGC TGGCAGGACG CGCCCCTCGG CCCCATCAAC CTGAGATGAG AA - #CAACATGA 60 - AGAAGAAGTC TCTGCTCCCC CTCGGCCTGG CCATCGGCCT CGCCTCTCTC GC - #TGCCAGCC 120 - CTCTGATCCA GGCCAGCACC TACACCCAGA CCAAATACCC CATCGTGCTG GC - #CCACGGCA 180 - TGCTCGGCTT CGACAATATC CTCGGGGTCG ACTACTGGTT CGGCATTCCC AG - #CGCCTTGC 240 - GCCGTGACGG TGCCCAGGTC TACGTCACCG AAGTCAGCCA GTTGGACACC TC - #GGAAGTCC 300 - GCGGCGAGCA GTTGCTGCAA CAGGTGGAGG AAATCGTCGC CCTCAGCGGC CA - #GCCCAAGG 360 - TCAACCTGAT CGGCCACAGC CACGGCGGGC CGACCATCCG CTACGTCGCC GC - #CGTACGTC 420 - CCGACCTGAT GCCTTCCGCC ACCAGCGTCG GCGCCCCGCA CAAGGGTTCG GA - #CACCGCCG 480 - ACTTCCTGCG CCAGATCCCA CCGGGTTCGG CCGGCGAGGC AGTCCTCTCC GG - #GCTGGTCA 540 - ACAGCCTCGG CGCGCTGATC AGCTTCCTTT CCAGCGGCAG CGCCGGTACG CA - #GAATTCAC 600 - TGGGCTCGCT GGAGTCGCTG AACAGCGAGG GGGCCGCGCG CTTCAACGCC AA - #GTACCCGC 660 - AGGGCATCCC CACCTCGGCC TGCGGCGAAG GCGCCTACAA GGTCAACGGC GT - #GAGCTATT 720 - ACTCCTGGAG CGGTTCCTCG CCGCTGACCA ACTTCCTCGA TCCGAGCGAC GC - #CTTCCTCG 780 - GCGCCTCGTC GCTGACCTTC AAGAACGGCA CCGCCAACGA CGGCCTGGTC GG - #CACCTGCA 840 - GTTCGCACCT GGGCATGGTG ATCCGCGACA ACTACCGGAT GAACCACCTG GA - #CGAGGTGA 900 - ACCAGGTCTT CGGCCTCACC AGCCTGTTCG AGACCAGCCC GGTCAGCGTC TA - #CCGCCAGC 960 - ACGCCAACCG CCTGAAGAAC GCCAGCCTGT AGGACCCCGG CCGGGGCCTC GG - #CCCCGGCC 1020 - CTTTCCCGGA AGCCCCCTCG CGTGAAGAAA ATCCTCCTGC TGATTCCACT GG - #CGTTCGCC 1080 #                 110 - #0 - (2) INFORMATION FOR SEQ ID NO:5: -      (i) SEQUENCE CHARACTERISTICS: #pairs    (A) LENGTH: 1635 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear -     (ii) MOLECULE TYPE: cDNA -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:5: - CAGGCCCCCA CGGCCGTTCT TAATGGCAAC GAGGTCATCT CTGGTGTCCT TG - #GGGGCAAG 60 - GTTGATACCT TTAAGGGAAT TCCATTTGCT GACCCTCCTG TTGGTGACTT GC - #GGTTCAAG 120 - CACCCCCAGC CTTTCACTGG ATCCTACCAG GGTCTTAAGG CCAACGACTT CA - #GCTCTGCT 180 - TGTATGCAGC TTGATCCTGG CAATGCCATT TCTTGGCTTG ACAAAGTCGT GG - #GCTTGGGA 240 - AAGATTCTTC CTGATAACCT TAGAGGCCCT CTTTATGACA TGGCCCAGGG TA - #GTGTCTCC 300 - ATGAATGAGG ACTGTCTCTA CCTTAACGTT TTCCGCCCTG CTGGCACCAA GC - #CTGATGCT 360 - AAGCTCCCCG TCATGGTTTG GATTTACGGT GGTGCCTTTG TGTTTGGTTC TT - #CTGCTTCT 420 - TACCCTGGTA ACGGCTACGT CAAGGAGAGT GTGGAAATGG GCCAGCCTGT TG - #TGTTTGTT 480 - TCCATCAACT ACCGTACCGG CCCCTATGGA TTCCTGGGTG GTGATGCCAT CA - #CCGCTGAG 540 - GGTAACACCA ACGCTGGTCT GCACGACCAG CGCAAGGGTC TCGAGTGGGT TA - #GCGACAAC 600 - ATTGCCAACT TTGGTGGTGA TCCCGACAAG GTCATGATTT TCGGTGAGTC CG - #CTGGTGCC 660 - ATGAGTGTTG CTCACCAGCT TGTTGCCTAC GGTGGTGACA ACACCTACAA CG - #GAAAGAAG 720 - CTTTTCCACT CTGCCATTCT TCAGTCTGGC GGTCCTCTTC CTTACTTTGA CT - #CTACTTCT 780 - GTTGGTCCCG AGAGTGCCTA CAGCAGATTT GCTCAGTATG CCGGATGTGA TG - #CCAGCGCC 840 - AGTGACAATG AAACTCTGGC TTGTCTCCGC AGCAAGTCCA GCGATGTCTT GC - #ACAGTGCC 900 - CAGAACTCGT ACGATCTCAA GGACCTGTTT GGCCTGCTCC CTCAATTCCT TG - #GATTTGGT 960 - CCCAGACCCG ACGGCAACAT TATTCCCGAT GCCGCTTATG AGCTCTACCG CA - #GCGGTAGA 1020 - TACGCCAAGG TTCCCTACAT TACTGGTAAC CAGGAGGATG AGGGTACTAT TC - #TTGCCCCC 1080 - GTTGCTATTA ATGCTACCAC GACTCCCCAT GTTAAGAAGT GGTTGAAGTA CA - #TTTGTAGC 1140 - GAGGCTTCTG ACGCTTCGCT TGATCGTGTT TTGTCGCTCT ACCCCGGCTC TT - #GGTCGGAG 1200 - GGTGCGCCAT TCCGCACTGG TATTCTTAAT GCTCTGACCC CTCAGTTCAA GC - #GCATTGCT 1260 - GCCATTTTCA CTGATTTGCT GTTCCAGTCT CCTCGTCGTG TTATGCTTAA CG - #CTACCAAG 1320 - GACGTCAACC GCTGGACTTA CCTTGCCACC CAGCTCCATA ACCTCGTTCC AT - #TTTTGGGT 1380 - ACTTTCCATG GTAGTGATCT TCTTTTCCAA TACTACGTGG ACCTTGGCCC AT - #CTTCTGCT 1440 - TACCGCCGCT ACTTTATCTC GTTTGCCAAC CACCACGACC CCAACGTTGG CA - #CCAACCTG 1500 - AAACAGTGGG ATATGTACAC TGATGCAGGC AAGGAGATGC TTCAGATTCA TA - #TGGTTGGT 1560 - AACTCTATGA GAACTGACGA CTTTAGAATC GAGGGAATCT CGAACTTTGA GT - #CTGACGTT 1620 #  1635 - (2) INFORMATION FOR SEQ ID NO:6: -      (i) SEQUENCE CHARACTERISTICS: #pairs    (A) LENGTH: 1650 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear -     (ii) MOLECULE TYPE: cDNA -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:6: - ATGGAGCTCG CTCTTGCGCT CCTGCTCATT GCCTCGGTGG CTGCTGCCCC CA - #CCGCCACG 60 - CTCGCCAACG GCGACACCAT CACCGGTCTC AACGCCATCA TCAACGAGGC GT - #TCCTCGGC 120 - ATTCCCTTTG CCGAGCCGCC GGTGGGCAAC CTCCGCTTCA AGGACCCCGT GC - #CGTACTCC 180 - GGCTCGCTCG ATGGCCAGAA GTTCACGCTG TACGGCCCGC TGTGCATGCA GC - #AGAACCCC 240 - GAGGGCACCT ACGAGGAGAA CCTCCCCAAG GCAGCGCTCG ACTTGGTGAT GC - #AGTCCAAG 300 - GTGTTTGAGG CGGTGCTGCC GCTGAGCGAG GACTGTCTCA CCATCAACGT GG - #TGCGGCCG 360 - CCGGGCACCA AGGCGGGTGC CAACCTCCCG GTGATGCTCT GGATCTTTGG CG - #GCGGGTTT 420 - GAGGTGGGTG GCACCAGCAC CTTCCCTCCC GCCCAGATGA TCACCAAGAG CA - #TTGCCATG 480 - GGCAAGCCCA TCATCCACGT GAGCGTCAAC TACCGCGTGT CGTCGTGGGG GT - #TCTTGGCT 540 - GGCGACGAGA TCAAGGCCGA GGGCAGTGCC AACGCCGGTT TGAAGGACCA GC - #GCTTGGGC 600 - ATGCAGTGGG TGGCGGACAA CATTGCGGCG TTTGGCGGCG ACCCGACCAA GG - #TGACCATC 660 - TTTGGCGAGC TGGCGGGCAG CATGTCGGTC ATGTGCCACA TTCTCTGGAA CG - #ACGGCGAC 720 - AACACGTACA AGGGCAAGCC GCTCTTCCGC GCGGGCATCA TGCAGCTGGG GG - #CCATGGTG 780 - CCGCTGGACG CCGTGGACGG CATCTACGGC AACGAGATCT TTGACCTCTT GG - #CGTCGAAC 840 - GCGGGCTGCG GCAGCGCCAG CGACAAGCTT GCGTGCTTGC GCGGTGTGCT GA - #GCGACACG 900 - TTGGAGGACG CCACCAACAA CACCCCTGGG TTCTTGGCGT ACTCCTCGTT GC - #GGTTGCTG 960 - TACCTCCCCC GGCCCGACGG CGTGAACATC ACCGACGACA TGTACGCCTT GG - #TGCGCGAG 1020 - GGCAAGTATG CCAACATCCC TGTGATCATC GGCGACCAGA ACGACGAGGG CA - #CCTTCTTT 1080 - GGCACCCTGC TGTTGAACGT GACCACGGAT GCCCAGGCCC GCGAGTACTT CA - #AGCAGCTG 1140 - TTTGTCCACG CCAGCGACGC GGAGATCGAC ACGTTGATGA CGGCGTACCC CG - #GCGACATC 1200 - ACCCAGGGCC TGCCGTTCGA CACGGGTATT CTCAACGCCC TCACCCCGCA GT - #TCAAGAGA 1260 - ATCCTGGCGG TGCTCGGCGA CCTTGGCTTT ACGCTTGCTC GTCGCTACTT CC - #TCAACCAC 1320 - TACACCGGCG GCACCAAGTA CTCATTCCTC CTGAAGCAGC TCCTGGGCTT GC - #CGGTGCTC 1380 - GGAACGTTCC ACTCCAACGA CATTGTCTTC CAGGACTACT TGTTGGGCAG CG - #GCTCGCTC 1440 - ATCTACAACA ACGCGTTCAT TGCGTTTGCC ACGGACTTGG ACCCCAACAC CG - #CGGGGTTG 1500 - TTGGTGAAGT GGCCCGAGTA CACCAGCAGC CTGCAGCTGG GCAACAACTT GA - #TGATGATC 1560 - AACGCCTTGG GCTTGTACAC CGGCAAGGAC AACTTCCGCA CCGCCGGCTA CG - #ACGCGTTG 1620 #         1650     TGTT CTTTGTGTAA __________________________________________________________________________

## Claims

1. A process for producing fatty acids or derivatives of fatty acids from oleaginous plants, which comprises: coding for a lipase enzyme, and associated with said lipase gene, a promoter permitting an expression of said lipase gene either in cellular, extracellular or tissue compartments different from those in which the plant lipids accumulate, or by exogenous induction, to bring into contact the lipids and the lipase contained in said seeds or fruits, the lipids of the crushed material under the catalytic action of the lipase contained in the crushed material, and obtain the desired fatty acid derivatives.

2. Process according to claim 1, in which the transgenic oleaginous plants are produced by effecting a genetic transformation of a natural oleaginous plant, causing the genetically transformed plant to-reproduce sexually so as to produce transgenic seeds and using the said transgenic seeds in order to obtain transgenic plant progeny.

3. Process according to claim 2, wherein: expression cassette containing a lipase gene and a promoter controlling the expression of a specific protein in the seed, and introducing this expression cassette into the genome of the plant so as to express the lipase in the compartments of the seed where the specific protein accumulates,

4. Process according to claim 3, wherein said oleoginous plants are rapeseed plants, and the genetic transformation is effected starting from an expression cassette comprising a lipase gene and a napine promoter.

5. Process according to claim 2, wherein: expression cassette containing a lipase gene and a promoter that can be controlled in an exogenous manner, and introducing this expression cassette into the genome of the plant, so as to induce synthesis of the lipase.

6. Process according to claim 5, wherein: comprising a lipase gene and a stress promoter, or fruits before crushing.

7. Process according to claim 2, wherein: expression cassette comprising a constitutive promoter and a lipase gene provided with a signal sequence for cellular or extracellular compartments different from those where the lipids accumulate,

8. Process according to claim 2, in which the genetic transformation of the plant is carried out by producing an expression cassette containing the lipase gene and the associated promoter, and by introducing this expression cassette into the genome of somatic cells of the plant by a transfer selected from the group consisting of bacterium Agrobacterium tumefaciens, electroporation, biolistics, and microinjection.

9. Process according to claim 2, in which the genetic transformation of the plant is carried out by producing an expression cassette containing the lipase gene and the associated promoter, and by introducing this expression cassette into the genome of microspores of the plant by electroporation or biolistics.

10. Process according to claim 1, wherein transgenic plants are produced containing a lipase gene having a non-specific hydrolytic activity in order to achieve a complete hydrolysis of the lipids.

11. Process according to claim 8, wherein transgenic plants are produced containing a lipase gene having a sequence identical or similar to one of SEQ ID NOS:1-6.

12. Process according to claim 1, in which the incubation to induce enzymatic hydrolysis is carried out at a temperature between 20.degree. C. and 60.degree. C.

13. Process according to claim 1, in which the extraction of the fatty acids produced by the hydrolysis is carried out by a liquid/liquid extraction using a non-polar solvent.

14. Process according to claim 1, in which the fatty acids produced by the hydrolysis are methylated in situ by contact with methanol under acid catalysis and ultrasound in order to convert them into methyl esters, the latter being extracted by a liquid/liquid extraction using a non-polar solvent.

15. A plant or plant seed, containing in its genome an expression cassette having at least one gene coding for an enzyme, associated with a promoter permitting an expression of said gene in cellular, extracellular or tissue compartments, wherein: lipids in specific lipid compartments, the lipids, expression of the gene in compartments different from the lipid compartments of the plant or seed so as to prevent contact between lipids and lipases produced by the plant.

16. The plant or seed according to claim 15, in which the promoter associated with the lipase gene is a cellular expression promoter or specific tissue promoter.

17. The plant or seed according to claim 15, in which the lipase gene is provided with a signal sequence for cellular or extracellular compartments different from the lipid accumulation compartments, the promoter being a constitutive promoter.

18. A plant or plant seed, containing in its genome an expression cassette having at least one gene coding for an enzyme, associated with a promoter permitting an expression of said gene, wherein: lipids in specific lipid compartments, the lipids, capable of controlling the production of lipase under the action of an exogenous signal.